Navigation Links
PDL BioPharma to Present at Two Upcoming Investor Conferences
Date:2/20/2013

INCLINE VILLAGE, Nev., Feb. 20, 2013  /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the following upcoming conferences.

RBC Capital Markets Healthcare Conference
Wednesday, February 27, 2013
9:00 a.m. ET
New York City

Cowen and Company 33rd Annual Healthcare Conference
Wednesday, March 6, 2013
9:20 a.m. ET
Boston, MA

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

To access the live and subsequently archived webcasts of the presentations, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.


'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
2. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
3. Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013
4. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
5. Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013
6. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
7. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
8. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
9. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
10. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2020)... Calif. (PRWEB) , ... May 26, 2020 , ... ... the most recognized brand of smart garage door openers, announce a new integration to ... of Wi-Fi enabled garage door openers powered by Aladdin Connect® can now be controlled ...
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased to announce its growth ... a biotechnology and medical technology-focused strategy and M&A advisory firm. , This is an ... linking US and Asia Pacific healthcare innovators with capital and investors. , Popper and ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... multiple open heart surgeries before becoming adults. The reason: there are ... address this critical unmet need, the Department of Defense has awarded Draper, Boston ...
(Date:5/14/2020)... (PRWEB) , ... May 12, 2020 , ... ... Interdisp JCS as the new distribution partner for all personal care ingredients in ... GENENCARE®OSMS portfolio and DuPont preservative portfolio for personal care. , The ...
Breaking Biology Technology:
(Date:4/26/2020)... , ... April 23, 2020 , ... ... in computer miniaturization, backed by FII Tech Growth managed by Fondo Italiano d’Investimento ... the biomedical market, for the development of Respira, a new non-invasive pulmonary ventilator ...
(Date:4/23/2020)... ... April 23, 2020 , ... ... recruitment plans. MDG provides critical infrastructure products for the animal feed, human consumption, ... plans for expansion. Further, as supply channels from overseas competitors have become weakened ...
(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. announced it ... provides patent development support for early stage startups. The investment will support Captis’ ... cancer and precancerous pancreatic lesions with simple, accurate and practical technology. , “We ...
Breaking Biology News(10 mins):